Kaltiala-Heino Riittakerttu, Bergman Hannah, Työläjärvi Marja, Frisén Louise
Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
Department of Adolescent Psychiatry, Tampere University Hospital, Tampere, Finland.
Adolesc Health Med Ther. 2018 Mar 2;9:31-41. doi: 10.2147/AHMT.S135432. eCollection 2018.
Increasing numbers of adolescents are seeking treatment at gender identity services in Western countries. An increasingly accepted treatment model that includes puberty suppression with gonadotropin-releasing hormone analogs starting during the early stages of puberty, cross-sex hormonal treatment starting at ~16 years of age and possibly surgical treatments in legal adulthood, is often indicated for adolescents with childhood gender dysphoria (GD) that intensifies during puberty. However, virtually nothing is known regarding adolescent-onset GD, its progression and factors that influence the completion of the developmental tasks of adolescence among young people with GD and/or transgender identity. Consolidation of identity development is a central developmental goal of adolescence, but we still do not know enough about how gender identity and gender variance actually evolve. Treatment-seeking adolescents with GD present with considerable psychiatric comorbidity. There is little research on how GD and/or transgender identity are associated with completion of developmental tasks of adolescence.
在西方国家,越来越多的青少年在性别认同服务机构寻求治疗。一种越来越被接受的治疗模式包括:在青春期早期开始使用促性腺激素释放激素类似物抑制青春期发育,约16岁开始进行跨性别激素治疗,在达到法定成年年龄后可能进行手术治疗,这种模式通常适用于患有童年性别焦虑症(GD)且在青春期加剧的青少年。然而,对于青少年期起病的性别焦虑症、其发展过程以及影响患有性别焦虑症和/或跨性别身份的年轻人完成青春期发育任务的因素,我们几乎一无所知。身份认同发展的巩固是青春期的核心发展目标,但我们对性别认同和性别差异实际上是如何演变的了解仍然不足。寻求治疗的患有性别焦虑症的青少年存在相当多的精神疾病共病情况。关于性别焦虑症和/或跨性别身份与青春期发育任务的完成之间如何关联,几乎没有相关研究。